STOCKSCREENR

CLDI

AMEX

Calidi Biotherapeutics, Inc.

$0.22-0.02(-8.69%)Mkt Cap: $1.59M

Key Stats

Market Cap

$1.59M

P/E Ratio

-0.04

EPS

$-5.95

Dividend Yield

0.00%

52-Week Range

$0.19 — $19.20

Volume

1.53M

Avg Volume

3.54M

Beta

1.42

Price Alerts for CLDI

Get alerted when CLDI hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.04

Forward P/E

—

PEG Ratio

-0.00

P/S (TTM)

0.00

P/B (TTM)

0.49

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-4.11%

ROA (TTM)

-2.25%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.52

Current Ratio

1.59

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-8.36%

EPS Growth (5Y)

-3.75%

Sales Growth (3Y)

-0.63%

Sales Growth (5Y)

-0.38%

EPS Est (This Year)

$-5.52

EPS Est (Next Year)

$-4.80

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.78

Analyst Consensus

Price Target Range

$2.00$5.50$9.00
LowMedianHigh

Consensus Target: $5.50(2441.6% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

7.17M

Float

5.59M

Free Float %

77.93%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

AMEX

IPO Date

2021-11-01

Employees

28

CEO

Eric E. Poma

Index Membership

—

Website

https://calidibio.com

Calidi Biotherapeutics, Inc. (CLDI) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $1.59M, a P/E ratio of -0.04, CLDI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CLDI against other stocks using dozens of fundamental and technical filters.

Similar Stocks

IBO.V

Universal Ibogaine Inc.

$0.01

-50.00%

$1.56M

MTNB

Matinas BioPharma Holdings, Inc.

$0.70

+7.47%

$3.88M

AIM

AIM ImmunoTech Inc.

$0.52

-0.64%

$1.75M

AZTR

Azitra, Inc.

$0.25

+0.45%

$2.66M

NFX.L

Nuformix plc

$0.17

+0.00%

$3.59M

BRTX

BioRestorative Therapies, Inc.

$0.23

+3.60%

$2.10M

Frequently Asked Questions

What is Calidi Biotherapeutics, Inc.'s P/E ratio?

Calidi Biotherapeutics, Inc. (CLDI) has a trailing twelve-month (TTM) P/E ratio of -0.04. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Calidi Biotherapeutics, Inc. pay a dividend?

No, Calidi Biotherapeutics, Inc. (CLDI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Calidi Biotherapeutics, Inc.'s market cap?

Calidi Biotherapeutics, Inc. (CLDI) has a market capitalization of $1.59 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.